N
THRN

Natixis’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Natixis’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60,000
Closed -$611K – 1225
2023
Q3 		$611K Buy
+60,000
New +$457K ﹤0.01% 577

Natixis's THRN Position: Q4 2023 in Review

Natixis sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 60,000 shares — an estimated $611K sold.

Natixis first reported a position in THRN in Q3 2023 and held it in 1 quarter. The position peaked at $611K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Natixis reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Natixis sold 60,000 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $611K.
  • Natixis first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Natixis's Thorne Healthtech, Inc. Common Stock position peaked at $611K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Natixis's 13F filing for Q4 2023, filed 13 Feb 2024.